Skip to main content
. 2014 Aug 17;2014:123079. doi: 10.1155/2014/123079

Table 2.

Patients' outcome according to PB-WT1 levels (</≥5 WT1/ABL × 104) evaluated before and after allo-SCT.

PB-WT1/ABL × 104 ≥ 5 PB-WT1/ABL × 104 < 5 P
Before allo-SCT
 Number of cases 11 13
 Number of relapses 8 (73%) 4 (31%) 0.04
At 3rd month after allo-SCT
 Number of cases 9 13
 Number of relapses 5 (56%) 5 (38%) 0.43
At 6th month after allo-SCT
 Number of cases 7 10
 Number of relapses 5 (71%) 2 (20%) 0.03